Shanghai – September 08, 2026 -- Pulnovo Medical's pulmonary artery denervation (PADN) system reduced the risk of clinical worsening by 51% in patients with pulmonary hypertension linked to left heart disease, according to results from the PADN-HF-PH trial presented at the European Society of Cardiology (ESC) 2026 Congress and published simultaneously in The New England Journal of Medicine (NEJM).

Washington – September 08, 2026 -- Total money market fund assets rose by $44.75 billion to $7.98 trillion for the week ended September 2, according to the Investment Company Institute.

Government funds drive the bulk of the weekly inflow

Among taxable money market funds, government funds increased by $38.80 billion, while prime funds added $4.92 billion. Tax-exempt money market funds gained $1.03 billion over the same period.

New York – September 08, 2026 -- The US economy added only 36.5K jobs in August 2026, according to a corrected release from workforce intelligence firm Revelio Labs, which had initially and erroneously reported a gain of 218.6K jobs. The correction accompanies the launch of Revelio's new Monthly Workforce Update, combining its Public Labor Statistics (RPLS) with its AI Labor Market Tracker.

Beijing/Florence – September 08, 2026 -- Gan & Lee Pharmaceuticals (603087.SH) has signed an exclusive license agreement with Italy's Menarini Group worth up to €726 million, excluding royalties, to develop and commercialize the obesity drug bofanglutida across 39 European markets.

Vancouver, BC – September 08, 2026 -- Red Metal Resources Ltd. (CSE: RMES) (OTCPINK: RMESF) (FSE: I660) has completed its first copper sulphide ore deliveries to Empresa Nacional de Minería's (ENAMI) Vallenar processing plant, roughly four months ahead of the seven-month development timeline set out in its mining lease.

Norwalk, Conn. – September 08, 2026 -- Bitmine Immersion Technologies (NYSE: BMNR) reported total crypto, cash and moonshot holdings of $15.6 billion as of August 30, 2026, with Ethereum holdings reaching 5,901,112 ETH.

Boston – September 08, 2026 -- Superluminal Medicines has closed an oversubscribed $60 million Series B financing led by BVF Partners, L.P., to fund a Phase 1 clinical trial for rare genetic forms of obesity expected to begin by the end of 2026.

Valcourt, QC – September 08, 2026 -- BRP Inc. (TSX: DOO; NASDAQ: DOO) reported second-quarter revenue of $2,236.8 million, up 18.5% from $1,888.2 million a year earlier, even as the company swung to a net loss of $136.8 million after tariff costs and a supplier restructuring charge hit margins.

Taipei – September 08, 2026 -- LITEON Technology (2301.TW) has agreed to acquire approximately 25% equity ownership in Warsaw-based DCX Liquid Cooling Systems in a transaction valued at approximately US$176 million.

Beijing – September 08, 2026 -- Gan & Lee Pharmaceuticals (603087.SH) has signed an exclusive license agreement with Italy's Menarini Group worth up to EUR 726 million, excluding royalties, to register and commercialize its GLP-1 receptor agonist bofanglutide for obesity and overweight treatment across 39 countries.